Literature DB >> 12928077

The role of gastroesophageal reflux in idiopathic pulmonary fibrosis.

Ganesh Raghu1.   

Abstract

Fibroblast foci are indicative of idiopathic pulmonary fibrosis and appear to be a cellular attempt to repair the damaged alveolus. Although this progressive, often fatal, clinical syndrome is thought to be dependent on alveolar injury of unknown origin, significant clinical and preclinical evidence points to gastric acid as a causative harmful agent. Graded instillation of various forms of acid in several animal models resulted in aspiration-induced lung injury, including pulmonary fibrosis in pigs. Moreover, compelling clinical data suggest that a high percentage of patients with idiopathic pulmonary fibrosis also experience abnormal esophageal acid exposure, without necessarily experiencing the typical symptoms of gastroesophageal reflux disease (GERD). Aggressive, long-term therapeutic trials of patients with GERD and evaluation of the therapeutic effects on pulmonary disease will allow determination of the real influences of abnormal esophageal acid exposure in the development of idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Year:  2003        PMID: 12928077     DOI: 10.1016/s0002-9343(03)00195-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Authors:  Gary W Hunninghake; Marvin I Schwarz
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

2.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

Review 3.  Does chronic microaspiration cause idiopathic pulmonary fibrosis?

Authors:  Joyce S Lee; Harold R Collard; Ganesh Raghu; Matthew P Sweet; Steven R Hays; Guilherme M Campos; Jeffrey A Golden; Talmadge E King
Journal:  Am J Med       Date:  2010-04       Impact factor: 4.965

4.  Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome.

Authors:  Joseph L Bobadilla; Ewa Jankowska-Gan; Qingyong Xu; Lynn D Haynes; Alejandro Munoz del Rio; Keith Meyer; Daniel S Greenspan; Nilto De Oliveira; William J Burlingham; James D Maloney
Journal:  Chest       Date:  2010-04-23       Impact factor: 9.410

Review 5.  [Bronchopulmonary manifestations of gastroesophageal reflux disease].

Authors:  M V Malfertheiner; A Kandulski; P Malfertheiner; J Schreiber
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

6.  The prevalence of obstructive sleep apnea in interstitial lung disease: a systematic review and meta-analysis.

Authors:  Yang Cheng; Yan Wang; Li Dai
Journal:  Sleep Breath       Date:  2021-01-06       Impact factor: 2.816

Review 7.  Rethinking Idiopathic Pulmonary Fibrosis.

Authors:  Justin M Oldham; Carlo Vancheri
Journal:  Clin Chest Med       Date:  2021-06       Impact factor: 4.967

8.  Bronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control study.

Authors:  Emilija Lozo Vukovac; Mislav Lozo; Kornelija Mise; Ivan Gudelj; Željko Puljiz; Anamarija Jurcev-Savicevic; Anteo Bradaric; Josipa Kokeza; Josko Mise
Journal:  Med Sci Monit       Date:  2014-02-15

9.  Towards a global initiative for fibrosis treatment (GIFT).

Authors:  Maria Molina-Molina; Alvar Agusti; Bruno Crestani; David A Schwartz; Melanie Königshoff; Rachel C Chambers; Toby M Maher; Rosa Faner; Ana Lucia Mora; Mauricio Rojas; Katerina M Antoniou; Jacobo Sellares
Journal:  ERJ Open Res       Date:  2017-12-01

10.  Intermittent Hypoxia Increases the Severity of Bleomycin-Induced Lung Injury in Mice.

Authors:  Thomas Gille; Morgane Didier; Cécile Rotenberg; Eva Delbrel; Dominique Marchant; Angela Sutton; Nicolas Dard; Liasmine Haine; Nicolas Voituron; Jean-François Bernaudin; Dominique Valeyre; Hilario Nunes; Valérie Besnard; Emilie Boncoeur; Carole Planès
Journal:  Oxid Med Cell Longev       Date:  2018-03-14       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.